Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone

Calcified Tissue International

Volumn 86, Issue 1, 2010, Pages 67-71

  Allen, Matthew R ^a   Erickson, Antonia M ^c   Wang, Xiang ^c,d   Burr, David B ^a,b   Martin, R Bruce ^c   Hazelwood, Scott J ^e  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CALIFORNIA POLYTECHNIC STATE UNIVERSITY   (United States)

Author keywords

Alendronate; Antiresorptive; Basic multicellular unit (BMU); Histomorphometry; Risedronate; Trabecular bone

Indexed keywords

ALENDRONIC ACID; RISEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE STRUCTURE; CONTROLLED STUDY; DRUG MECHANISM; EXPERIMENTAL DOG; FEMALE; LOW DRUG DOSE; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; TRABECULAR BONE;

ALENDRONATE; ANIMALS; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; CELL AGGREGATION; CELL PROLIFERATION; DIPHOSPHONATES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETIDRONIC ACID; FEMALE; HUMANS; MODELS, ANIMAL; OSTEOCLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; TREATMENT OUTCOME;

EID: 73649094728     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-009-9315-x     Document Type: Article

References (14)

1. RG Russell NB Watts FH Ebetino MJ Rogers 2008 Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy Osteoporos Int 19 733 759 10.1007/s00198-007-0540-8 1:CAS:528:DC%2BD1cXltFyjurw%3D 18214569
2. GA Rodan HA Fleisch 1996 Bisphosphonates: mechanisms of action J Clin Invest 97 2692 2696 10.1172/JCI118722 1:CAS:528:DyaK28XjvVWksrw%3D 8675678
3. RW Boyce CL Paddock JR Gleason WK Sletsema EF Eriksen 1995 The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site J Bone Miner Res 10 211 221 1:CAS:528:DyaK2MXmslSktL8%3D 7754801
4. ME Cohen-Solal MS Shih MW Lundy AM Parfitt 1991 A new method for measuring cancellous bone erosion depth: application to the cellular mechanisms of bone loss in postmenopausal osteoporosis J Bone Miner Res 6 1331 1338 1:STN:280:DyaK387ntVequw%3D%3D 1792944
5. C Roux P Ravaud M Cohen-Solal MC de Vernejoul S Guillemant B Cherruau P Delmas M Dougados B Amor 1994 Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma Bone 15 41 49 10.1016/8756-3282(94)90890-7 1:STN:280:DyaK2c3ps1OgtQ%3D%3D 8024850 (Pubitemid 24107941)
6. JP Roux ME Arlot E Gineyts PJ Meunier PD Delmas 1995 Automatic- interactive measurement of resorption cavities in transiliac bone biopsies and correlation with deoxypyridinoline Bone 17 153 156 10.1016/S8756-3282(95)00174-3 1:STN:280:DyaK28%2FitFeksg%3D%3D 8554923
7. PM Chavassieux ME Arlot C Reda L Wei AJ Yates PJ Meunier 1997 Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis J Clin Invest 100 1475 1480 10.1172/JCI119668 1:CAS:528:DyaK2sXmt1Cqsb8%3D 9294113
8. EF Eriksen F Melsen E Sod I Barton A Chines 2002 Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis Bone 31 620 625 10.1016/S8756-3282(02)00869-4 1:CAS:528: DC%2BD38XptlGisrk%3D 12477578 (Pubitemid 35449706)
9. T Storm T Steiniche G Thamsborg F Melsen 1993 Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis J Bone Miner Res 8 199 208 1:STN:280: DyaK3s7ot1Khuw%3D%3D 8442438
10. MR Allen K Iwata R Phipps DB Burr 2006 Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate Bone 39 872 879 10.1016/j.bone.2006.04.028 1:CAS:528:DC%2BD28XpsVOhurY%3D 16765660 (Pubitemid 44311727)
11. EF Eriksen 1986 Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease Endocr Rev 7 379 408 10.1210/edrv-7-4-379 1:STN:280:DyaL2s%2FltlOjsw%3D%3D 3536460
12. EF Eriksen L Mosekilde F Melsen 1985 Effect of sodium fluoride, calcium, phosphate, and vitamin D2 on trabecular bone balance and remodeling in osteoporotics Bone 6 381 389 10.1016/8756-3282(85)90337-0 1:STN:280: DyaL287lvFCjuw%3D%3D 3879454 (Pubitemid 16185004)
13. EF Eriksen SF Hodgson R Eastell SL Cedel WM O'Fallon BL Riggs 1990 Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels J Bone Miner Res 5 311 319 1:STN:280:DyaK3c3mtFGhtQ%3D%3D 2343771
14. EV Tkachenko CR Slyfield RE Tomlinson JR Daggett DL Wilson CJ Hernandez 2009 Voxel size and measures of individual resorption cavities in three-dimensional images of cancellous bone Bone 45 487 492 10.1016/j.bone.2009. 05.019 19482097